Table 1.
Demographic and clinical characteristics of ADHD patients.
| Baseline | 3 months | 6 months | 12 months | |
|---|---|---|---|---|
| N | 208 | 172 | 183 | 176 |
| Age | ||||
| Mean (SD) | 10.6 (2.9) | 10.7 (2.9) | 10.5 (2.8) | 10.5 (2.8) |
| Range | 6–18 | 6–18 | 6–18 | 6–18 |
| Gender | ||||
| Male (%) | 163 (78.3) | 136 (79.1) | 145 (79.2) | 138 (78.4) |
| Female (%) | 45 (21.7) | 36 (20.9) | 38 (20.8) | 38 (21.6) |
| ADHD diagnosis | ||||
| Combined type (%) | 121 (58.2) | 99 (57.7) | 106 (57.9) | 105 (59.6) |
| Inattentive type (%) | 78 (37.5) | 66 (38.4) | 69 (37.7) | 65 (36.9) |
| Hyperactive type (%) | 9 (4.3) | 7 (4.1) | 8 (4.4) | 6 (3.5) |
| Previous treatment | ||||
| Naive patients (%) | 57 (27.4) | 47 (27.3) | 46 (25.1) | 47 (26.7) |
| Experienced patients (%) | 151 (72.6) | 125 (72.7) | 137 (74.9) | 129 (73.3) |
| Methylphenidate | ||||
| Immediate-release (%) | 17 (8.2) | 13 (7.6) | 8 (4.4) | 8 (4.5) |
| Extended-release (%) | 173 (83.1) | 144 (83.7) | 155 (84.7) | 143 (81.3) |
| Both at the same time (%) | 18 (8.7) | 15 (8.7) | 20 (10.9) | 25 (14.2) |
| Doses mg/day | ||||
| Mean (SD) | 35.5 (15) | 39.5 (15.7) | 39.4 (15.8) | 40.5 (15.5 |
| Cases with at least one side effect (%) | 51 (29.6) | 72 (39.3) | 47 (26.7) | |
| CGI-S score | ||||
| Mean (SD) | 3.24 (0.58) | 3.10 (0.56) | 3.06 (0.55) | 3.07 (0.57) |
| CGAS score | ||||
| Mean (SD) | 69.15 (11.67) | 74.62 (9.26) | 75.26 (9.69) | 75.90 (9.29) |